EBOT

It gives an external, European-standard measure of oncology knowledge for trainees completing specialist training and for practising oncologists. Many use it to identify gaps before independent practice or to support applications. It complements, but does not replace, national certification requirements, so confirm with your national authority how results are recognised locally.

Expect clinically framed multiple-choice questions spanning the full syllabus, with an emphasis on the next best step, interpretation of results and evidence-based choice of treatment. The official body publishes the current format, item count and timing on its website, and these have changed between sittings, so verify the details for your sitting rather than relying on what earlier candidates describe.

Candidates generally find it demanding because it rewards applied reasoning across the whole of oncology rather than depth in one subspecialty. The passing standard is set by the examining body and is published on its site; do not rely on secondhand figures. Aim to be comfortably above any published threshold rather than targeting the minimum.

Retake rules, limits on attempts and any waiting period are set by the examining body and vary by sitting. Check the current regulations on the official website before you register, and note whether a failed attempt affects eligibility for the next cycle. Build your first attempt as if it is the only one, since resit logistics add cost and delay.

Most candidates need several months of steady work alongside clinical duties. A practical pattern is to spend the first half of your time on the full syllabus with guidelines and a general text, then the second half on case-based practice and reviewing your weak domains. Short, frequent sessions and spaced repetition beat last-minute blocks for retention.

Start with clinical assessment and diagnosis, because staging and work-up logic underpin every treatment question. Then take systemic therapy, the largest domain, followed by radiation and surgical oncology as multidisciplinary partners. Finish with supportive care, emergencies, research methods and professionalism, and revisit them regularly, since these are easy to neglect and carry real weight.

Three recur: knowing a drug's mechanism but not when to choose it; weak handling of trial design, endpoints and statistics questions; and neglect of supportive care, emergencies and communication scenarios treated as low-yield. A fourth is poor time discipline on long clinical vignettes. Practising timed question sets exposes all four before the real sitting does.

Answer before reading the explanation, then write one line on why each wrong option fails. Group your errors by domain to see whether the gap is knowledge or reasoning. Revisit missed items after a few weeks; if you miss the same item twice, that domain needs rereading in a guideline or text rather than more questions.

No. This is an independent study resource written for candidates preparing for the exam. It is not affiliated with, endorsed by or produced in partnership with the examining body, and it does not reproduce official materials. Always treat the official website as the authoritative source for regulations, format and results.